SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008531
Filing Date
2022-05-09
Accepted
2022-05-09 16:34:20
Documents
70
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q stro-20220331.htm   iXBRL 10-Q 2999928
2 EX-31.1 stro-ex31_1.htm EX-31.1 18706
3 EX-31.2 stro-ex31_2.htm EX-31.2 18856
4 EX-32.1 stro-ex32_1.htm EX-32.1 9405
5 EX-32.2 stro-ex32_2.htm EX-32.2 9435
  Complete submission text file 0000950170-22-008531.txt   10840764

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stro-20220331.xsd EX-101.SCH 70922
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stro-20220331_def.xml EX-101.DEF 280059
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT stro-20220331_lab.xml EX-101.LAB 551634
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stro-20220331_cal.xml EX-101.CAL 45297
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stro-20220331_pre.xml EX-101.PRE 425273
64 EXTRACTED XBRL INSTANCE DOCUMENT stro-20220331_htm.xml XML 2131863
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38662 | Film No.: 22905616
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences